Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders

Haemophilia

Volumn 5, Issue 1, 1999, Pages 40-48

  Kadir, R A ^a   Economides, D L ^a   Sabin, C A ^a   Pollard, D ^a   Lee, C A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Carriers of haemophilia; Factor XI deficiency; Menorrhagia; Menstrual blood loss; Von Willebrand's disease

Indexed keywords

BLOOD CLOTTING FACTOR 11; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; AWARENESS; BLEEDING DISORDER; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CONTROLLED STUDY; CURETTAGE; DISEASE CARRIER; DISEASE SEVERITY; FEMALE; GYNECOLOGIC DISEASE; HEMOPHILIA; HUMAN; HYSTERECTOMY; HYSTEROSCOPY; INTERVIEW; MAJOR CLINICAL STUDY; MENORRHAGIA; MENSTRUATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; EVALUATION STUDIES; FACTOR XI DEFICIENCY; FEMALE; GENITAL DISEASES, FEMALE; HEMOPHILIA A; HEMOPHILIA B; HEMORRHAGIC DISORDERS; HUMANS; MENORRHAGIA; MIDDLE AGED; VON WILLEBRAND DISEASE;

EID: 0032969455     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.1999.00285.x     Document Type: Article

References (42)

1. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood 1987; 69: 454-9.
2. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr 1993; 123: 893-8.
3. Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on post-transfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 1977; 60: 390-404.
4. Ruggeri ZM. Pathogenesis and classification of von Willebrand disease. [Review] Haemostasis 1994; 24: 265-75.
5. Forbes CD. Clinical aspects of the hemophiliacs and their treatment. In: Ratnoff OD, Forbes CD, eds. Disorders of Haemostasis. Orlando: Grune & Stratton. 1984: 177-239.
6. Shpilberg O, Peretz H, Zivelin R, et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995; 85: 429-32.
7. Bolton-Maggs PH, Patterson DA, Wensley RT, Tuddenham EG. Definition of the bleeding tendency in factor XI-deficient kindreds: a clinical and laboratory study. Thromb Haemost 1995; 73: 194-202.
8. Christiaens GC, Sixma JJ, Haspels AA. Haemostasis in menstrual endometrium: a review. Obstet Gynecol Surv 1982; 37: 281-303.
9. Vinazzer H. Über Störungen der Hemostase als Ursache von Menorrhagien. Geburtshilfe Frauenheilkd 1966; 26: 743-5.
10. Nilsson IM. Haemorrhagic and Thrombotic Diseases London: John Wiley 1974: 97-8.
11. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
12. Claessens EA, Cowell CA. Dysfunctional uterine bleeding in the adolescent. Pediatr Clin North Am 1981; 28: 369-78.
13. Zimmermann TS, Ruggeri ZM. von Willebrand disease. Hum Pathol 1987; 18: 140-52.
14. Evans PC. Obstetric and gynecologic patients with von Willebrand's disease. Obstet Gynecol 1971; 38: 37-43.
15. Greer IA, Lowe GD, Walker JJ, Forbes CD. Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 1991; 98: 909-18.
16. Fraser IS, McCarron G, Markham R, Resta T, Watts A. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. Obstet Gynecol 1986; 68: 630-3.
17. Rizza CR, Rhymes IL, Austen DE, Kernoff PB, Aroni SA. Detection of carriers of hemophilia a 'blind' study. Br J Haematol 1975; 30: 447-56.
18. Rapaport SI, Patch MJ, Moore FJ. Anti-hemophilic globulin levels in carriers of hemophilia A. J Clin Invest 1960; 39: 1619-25.
19. Bunschoten EPM, van Houwelingen JC, Visser EJM, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988; 59: 349-52.
20. Lusher JM, McMillan CW, and the Hemophilia study group. Severe factor VIII and factor IX deficiency in females. Am J Med 1978; 65: 637-48.
21. Bolton-Maggs PHB, Young-Wang-Yin R, McCraw A, Slack J, Kernoff PBA. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-8.
22. Selihsohn U. Factor XI deficiency. Thromb Haemost 1993; 70: 68-71.
23. Cole SK, Billewicz WZ, Thomson AM. Sources of variation in menstrual blood loss. J Obstet Gynaecol Br Commonw 1971; 78: 933-9.
24. Haynes PJ, Hodgson H, Anderson AB, Turnbull AC. Measurement of menstrual blood loss in patients complaining of menorrhagia. Br J Obstet Gynaecol 1977; 84: 763-8.
25. Rees MC, Chimbira TH, Anderson AB, Turnbull AC. Menstrual blood loss: measurement and clinical correlates. Res Clin Forums 1982; 4: 69-80.
26. Hallberg L, Hogdahl AM, Nilsson L, Rybo G. Menstrual blood loss - a population study. Acta Obstet Gynecol Scand 1966; 45: 320-51.
27. Hallberg L, Nilsson L. Constancy of individual menstrual blood loss. Acta Obstet Gynec Scand 1964; 43: 352-9.
28. Newton J, Barnard G, Colins W. A rapid method for measuring menstrual blood loss using automatic extraction. Contraception 1977; 16: 269-85.
29. Vasilenko P, Kraicer PF, Kaplan R, deMasi A, Freed N. A new and simple method of measuring menstrual blood loss. J Reprod Med 1988; 33: 293-7.
30. Gannon MJ, Day P, Hammadieh N, Johnson N. A new method for measuring menstrual blood loss and its use in screening women before endometrial ablation. Br J Obstet Gynaecol 1996; 103: 1029-33.
31. Chimbria TH, Anderson ABM, Turnbull AC. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area. Br J Obstet Gynaecol 1980; 87: 603-9.
32. Mäkäräinen L, Ylikorkala O. Primary and myomaassociated menorrhagia: role of prostaglandins and effect of ibuprofen. Br J Obstet Gynaecol 1986; 93: 974-8.
33. Dockeray CJ, Sheppard BL, Daly L, Bonnar J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur J Obstet Gynecol Reprod Biol 1987; 24: 309-18.
34. Bonnar J, Guillebaud J, Kasonde JM, Sheppard BL. Clinical applications of fibrinolytic inhibition in gynaecology. J Clin Pathol 1980; 33 (Suppl. 14): 55-9.
35. Schiffman S, Rapaport SI. Increased factor VIII levels in suspected carriers of hemophilia A taking contraceptives by mouth. N Engl J Med 1966; 275: 599.
36. Leone G, Moneta E, Paparatti G, Boni P. von Willebrand's disease in pregnancy. N Engl J Med 1975; 293: 456.
37. Ramsahoye BH, Davis SV, Dasani H, Pearson JF. Obstetric management in von Willebrand's disease: a report of 24 pregnancies and a review of the literature. Haemophilia 1995; 1: 140-4.
38. Glueck HI, Flessa HC. Control of haemorrhage in von Willebrand's disease and a haemophiliac carrier with norethynordrelmestranol. Thromb Res 1972; 1: 253-66.
39. Alperin JB. Estrogens and surgery in women with von Willebrand's disease. Am J Med 1982; 73: 367-71.
40. Lethagen S, Harris A, Nilsson IM. Intranasal desmopressin (DDAVP) by spray in mild hemophilia A and von Willebrand's disease type 1. Blut 1990; 60: 187-91.
41. Rose EH, Adelort LM. Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann of Intern Med 1991; 114: 563-8.
42. Lethagen S, Ragnrson Tennvall G. Self-treatment with desmopresin intranasal spray in patients with bleeding disorders: effect on bleeding symptoms and socioeconomic factors. Ann Hematol 1993; 66: 257-60.